Kirsty Hillier/nyulangone.org; Taylor Olmsted Kim/ www.doximity.com; Thomas Pincez/LinkedIn
Apr 4, 2026, 09:03
Thomas Pincez: Mechanisms and Pathology of Immune Thrombocytopenia
Thomas Pincez, Adjunct Professor at McGill University, Assistant Professor at University of Montreal, Clinician-Scientist at Azrieli Research Centre of CHU Sainte-Justine, shared a post on LinkedIn about a recent article he and his colleagues co-authored, adding:
“Back in medical school, I had the feeling that pathophysiology was simple.
I quickly understood how far we are from really catching it…
We tried to wrap up the current knowledge in this review!”
Title: Immunopathology of immune thrombocytopenia
Authors: Kirsty Hillier, Taylor Olmsted Kim, Thomas Pincez
Read the Full Article on JTH

Stay updated on all scientific advances with Hemostasis Today.
-
Nov 15, 2026, 20:56Victoria Adedoyin Adisa-Thomas: What I Learned About SCD During My Genetic Counselling Rotation
-
Nov 15, 2026, 20:55Martin Holst Lange: One Step Closer to a Potential New Treatment for Sickle Cell Disease
-
Nov 15, 2026, 20:53Bontha Babu: Health-Related Quality of Life Among Adults with Sickle Cell Disease in India
-
Nov 15, 2026, 20:52Miguel Ángel Herrera Rojas: A First-Line ITP Approach Presented at ASH in 2013 Now Reflected in the 2026 Guidelines
-
Nov 15, 2026, 20:50Asmaa Beltagy: Efficacy and Safety of Eltrombopag in SLE-Associated Immune Thrombocytopenia
-
Nov 15, 2026, 16:29Jean-Jacques Kiladjian: 20 Years of Interferon-Alpha Research in Myeloproliferative Neoplasms
-
Nov 15, 2026, 16:21Sukanto Paul: Why Platelet Transfusion Is Generally Avoided in TTP
-
Nov 15, 2026, 16:14Ahmad G. Alzahrani: Major Bleeding and Anticoagulant Reversal
-
Nov 15, 2026, 16:05Sabine Eichinger: Is Recurrence Risk After Provoked VTE Really Low?